Outpatient therapy with Heberprot-P in patients with diabetic foot ulcers

Abstract

A study was performed to determine the results of outpatient therapy with Heberprot-P in five polyclinics of Guantanamo, from August 2011 to July 31, 2012. The study group is comprised of 84 patients diagnosed with diabetic foot ulcers (ischemic or neuroinfection), treated as outpatients with Heberprot-P by the multidisciplinary care team diabetic patient. The variables were studied: age, sex, and response to treatment, adverse reactions and location of the lesion. As Predominated age between 51 and 60 years old, female. Most of the patients obtained a complete response to treatment. Pain was the most frequent undesirable effect of patients. As a conclusion, Heberprot-P is an effective and safe treatment to accelerate the healing of diabetic foot ulcers and prevent amputation.